DMAQR — Deep Medicine Acquisition Balance Sheet
0.000.00%
Last trade - 00:00- $57.84m
- $52.90m
- 41
- 54
- 59
- 50
Annual balance sheet for Deep Medicine Acquisition, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 0.5 | 129 | 9.76 |
| Prepaid Expenses | |||
| Total Current Assets | 0.538 | 129 | 9.78 |
| Total Assets | 0.538 | 129 | 9.78 |
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 0.041 | 0.537 | 2.8 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 0.547 | 4.96 | 7.22 |
| Redeemable Preferred Stock | |||
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | -0.009 | 124 | 2.55 |
| Total Liabilities & Shareholders' Equity | 0.538 | 129 | 9.78 |
| Total Common Shares Outstanding |